Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?
Ritu Salani, MD, MBA
Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care
Saad Z. Usmani, MD, MBA, FACP
Joshua Richter, MD
Ashley Steinberger, APP
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Jody Takemoto, PhD, MEd
David Braun
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
David Braun, MD, PhD
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Hannah Lee, MD
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Munir Ghesani, MD
Enhancing HCC Outcomes Through Multidisciplinary Care
Charles Turck, PharmD, BCPS, BCCCP
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
Jennifer Caudle, DO
Patricia A. Mangan, RN, MSN, APRN-BC
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Robert Wong, MD
An Overview of the Fundamentals of PET-CT Imaging
Key Highlights from SNMMI 2024
An Exploration of Multiple Myeloma Treatments
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma
Jesus G. Berdeja, MD
Nicholas G. Barkemeyer, MPAS
Ajai Chari, MD
Harvey Church
Amy Gebhardt
Steven Morrow
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Matt Birnholz, MD
Saad Kenderian M.B, Ch.B
Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.